Reversible Pulmonary Hypertension in Heart Transplant Candidates—Pretransplant Evaluation and Outcome After Orthotopic Heart Transplantation
Authors:
- 1 October 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 5 (5) , 645-653
Abstract
Background: Heart transplantation is the most effective treatment for well-selected patients with endstage heart failure. Unfortunately, transplant candidates with pulmonary hypertension (PHT) are often not considered for heart transplantation. This study was performed to assess the value of prostaglandin E1 (PG-E1) for reduction of PHT and to predict the postoperative outcome, compared to patients without PHT. Patients and methods: We studied a group of 151 consecutive heart transplant candidates using right heart catheterization. In patients with PHT (pulmonary vascular resistance, PVR≥2.5 Wood-Units (WU) and/or transpulmonary gradient (TPG)≥12 mmHg) a short-term treatment protocol with PG-E1 was performed, to achieve PVR<2.5 WU and TPG<12 mmHg. Results: 61 patients (40%) had PHT according to our criteria. Reduction of PHT was successful in 71% of patients (n=43), of these, 18 patients underwent cardiac transplantation and the 1-year mortality rate was 22% (n=4). The 1-year mortality rate in transplanted patients without PHT was 14% (n=3). There was no statistical difference in survival between the PHT and the non-PHT group. Outcome in patients without heart transplantation was similar in both groups, except for patients with non-reducible PHT (1-year mortality 50%). Conclusions: Our study demonstrates the efficacy and safety of PG-E1 in lowering PHT in heart transplant candidates, as well as the need for aggressive evaluation and treatment in these patients. Patients with reversible PHT have comparable post-transplant outcomes and no tendency to higher acute right ventricular failure.Keywords
This publication has 22 references indexed in Scilit:
- Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial HypertensionCirculation, 2002
- Cardiac transplantationHeart, 2002
- Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantationThe Journal of Heart and Lung Transplantation, 2001
- Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortalityThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Prostaglandin E1--bridge to cardiac transplantation: Technique, dosage, resultsEuropean Heart Journal, 1997
- Heart transplant candidates at high risk can be identified at the time of initial evaluationTransplant International, 1996
- The Interdisciplinary Heart Failure and Transplant Program Münster: a 5-year experienceInternational Journal of Cardiology, 1995
- Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experienceAmerican Heart Journal, 1993
- Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk groupJACC, 1992
- Inactivation of Prostaglandins by the LungsNature, 1970